CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 87 filers reported holding CATALYST PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $8,000 | -95.7% | 2,000 | -95.4% | 0.00% | -96.1% |
| Q1 2015 | $186,000 | +45.3% | 43,025 | 0.0% | 0.08% | +54.0% |
| Q4 2014 | $128,000 | -10.5% | 43,025 | 0.0% | 0.05% | -19.4% |
| Q3 2014 | $143,000 | +25.4% | 43,025 | -4.3% | 0.06% | +37.8% |
| Q2 2014 | $114,000 | +16.3% | 44,950 | +3.2% | 0.04% | +21.6% |
| Q1 2014 | $98,000 | +66.1% | 43,550 | +45.2% | 0.04% | +60.9% |
| Q4 2013 | $59,000 | – | 30,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 589,883 | $590,000 | 1.38% |
| Broadfin Capital, LLC | 8,200,000 | $8,610,000 | 0.96% |
| Avoro Capital Advisors LLC | 1,141,149 | $1,198,000 | 0.24% |
| CORRADO ADVISORS, LLC | 190,600 | $200,000 | 0.12% |
| Baker Brothers Advisors | 5,102,153 | $5,357,000 | 0.05% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 756,311 | $794,000 | 0.04% |
| Point72 Asset Management, L.P. | 2,272,816 | $2,386,000 | 0.02% |
| AGRAN LIBBIE | 44,000 | $46,000 | 0.01% |
| COMPTON CAPITAL MANAGEMENT INC /RI | 10,000 | $11,000 | 0.01% |
| KENNEDY CAPITAL MANAGEMENT LLC | 233,171 | $245,000 | 0.00% |